OA10.06 Impact of Brain Metastases on Safety and Efficacy of MK-6070, a DLL3-Targeting T Cell Engager, in Small Cell Lung CancerNoura J. Choudhury, Prantesh Jain, Rachel E. Sanborn et al.|Journal of Thoracic Oncology|2024Cited by 12
2758MO Updated results from a phase I/II study of gocatamig for small cell lung cancer (SCLC) and other neuroendocrine cancersHimisha Beltran, A.J. Cooper, M.L. Johnson et al.|Annals of Oncology|2025Cited by 6